Predictors of high-risk and low-risk oral HPV infection in the United States

Laryngoscope

Volumn 126, Issue 6, 2016, Pages 1365-1372

  Orosco, Ryan K ^a   Kedarisetty, Suraj ^b   Hecht, Avram S ^a   Chang, David C ^c   Coffey, Charles S ^a   Weissbrod, Philip A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Human papillomavirus (HPV); NHANES; oral; oral sex; oropharynx; smoking

Indexed keywords

VIRUS DNA;

ADULT; AGED; CONFERENCE PAPER; ETHNICITY; FEMALE; GENDER; HIGH RISK PATIENT; HUMAN; INFECTION RISK; LOW RISK PATIENT; MALE; MOUTH INFECTION; NONHUMAN; ORAL SEX; PAPILLOMAVIRUS INFECTION; PREDICTIVE VALUE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SEXUAL BEHAVIOR; SOCIAL CLASS; UNITED STATES; WART VIRUS; ADOLESCENT; AGE; CROSS-SECTIONAL STUDY; MIDDLE AGED; NUTRITION; ODDS RATIO; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; SEX DIFFERENCE; SEXUALITY; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NUTRITION SURVEYS; ODDS RATIO; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; SEXUAL BEHAVIOR; SEXUAL PARTNERS; UNITED STATES; YOUNG ADULT;

EID: 84952815462     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.25822     Document Type: Conference Paper

References (21)

1. Munoz N, Bosch FX, de Sanjose S, et al., Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348: 518-527.
2. Hashibe M, Sturgis EM,. Epidemiology of oral-cavity and oropharyngeal carcinomas: controlling a tobacco epidemic while a human papillomavirus epidemic emerges. Otolaryngol Clin North Am 2013; 46: 507-520.
3. Chaturvedi AK, Engels EA, Pfeiffer RM, et al., Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 2011; 29: 4294-4301.
4. Fakhry C, Rosenthal BT, Clark DP, Gillison ML,. Associations between oral HPV16 infection and cytopathology: evaluation of an oropharyngeal "pap-test equivalent" in high-risk populations. Cancer Prev Res (Phila) 2011; 4: 1378-1384.
5. Broutian TR, He X, Gillison ML,. Automated high throughput DNA isolation for detection of human papillomavirus in oral rinse samples. J Clin Virol 2011; 50: 270-275.
6. Rettig EM, Wentz A, Posner MR, et al., Prognostic implication of persistent human papillomavirus type 16 DNA detection in oral rinses for human papillomavirus-related oropharyngeal carcinoma. JAMA Oncol 2015; 1: 907-915. doi: 10.1001/jamaoncol.2015.2524.
7. Snietura M, Rutkowski T, Piglowski W, et al., Human papillomavirus DNA in pharyngeal scrapes as a marker of HPV-related squamous cell cancer of the oropharynx. J Clin Virol 2015; 71: 34-39.
8. Hoffmann M, Quabius ES, Tribius S, et al., Human papillomavirus infection in head and neck cancer: the role of the secretory leukocyte protease inhibitor. Oncol Rep 2013; 29: 1962-1968.
9. Beachler DC, Weber KM, Margolick JB, et al., Risk factors for oral HPV infection among a high prevalence population of HIV-positive and at-risk HIV-negative adults. Cancer Epidemiol Biomarkers Prev 2012; 21: 122-133.
10. Kreimer AR, Alberg AJ, Daniel R, et al., Oral human papillomavirus infection in adults is associated with sexual behavior and HIV serostatus. J Infect Dis 2004; 189: 686-698.
11. Nguyen QT, Olson ES, Aguilera TA, et al., Surgery with molecular fluorescence imaging using activatable cell-penetrating peptides decreases residual cancer and improves survival. Proc Natl Acad Sci U S A 2010; 107: 4317-4322.
12. Gillison ML, Broutian T, Pickard RK, et al., Prevalence of oral HPV infection in the United States, 2009-2010. JAMA 2012; 307: 693-703.
13. Chaturvedi AK, Graubard BI, Pickard RK, Xiao W, Gillison ML,. High-risk oral human papillomavirus load in the US population, National Health and Nutrition Examination Survey 2009-2010. J Infect Dis 2014; 210: 441-447.
14. Antonsson A, Cornford M, Perry S, Davis M, Dunne MP, Whiteman DC,. Prevalence and risk factors for oral HPV infection in young Australians. PLoS One 2014; 9: e91761.
15. Davidson CL, Richter KL, Van der Linde M, Coetsee J, Boy SC,. Prevalence of oral and oropharyngeal human papillomavirus in a sample of South African men: a pilot study. S Afr Med J 2014; 104: 358-361.
16. Pickard RK, Xiao W, Broutian TR, He X, Gillison ML,. The prevalence and incidence of oral human papillomavirus infection among young men and women, aged 18-30 years. Sex Transm Dis 2012; 39: 559-566.
17. D'Souza G, Cullen K, Bowie J, Thorpe R, Fakhry C,. Differences in oral sexual behaviors by gender, age, and race explain observed differences in prevalence of oral human papillomavirus infection. PLoS One 2014; 9: e86023.
18. Herrero R, Quint W, Hildesheim A, et al., Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica. PLoS One 2013; 8: e68329.
19. Chaturvedi AK, Engels EA, Anderson WF, Gillison ML,. Incidence trends for human papillomavirus-related and unrelated oral squamous cell carcinomas in the United States. J Clin Oncol 2008; 26: 612-619.
20. Fakhry C, Gillison ML, D'Souza G,. Tobacco use and oral HPV-16 infection. JAMA 2014; 312: 1465-1467.
21. van Rijn VM, Mooij SH, Mollers M, et al., Anal, penile, and oral high-risk HPV infections and HPV seropositivity in HIV-positive and HIV-negative men who have sex with men. PLoS One 2014; 9: e92208.